Please wait while the formulary information is being retrieved.
RELADOR PAK (LIDOCAINE/PRILOCAINE)
- Administration of local anesthesia
- Relador Pak Topical Kit
- Relador Pak Plus Topical Kit
- Prilovix Ultralite Topical Kit
- Prilovix Ultralite Plus Topical Kit
- Prilovix Topical Kit
- Prilovix Plus Topical Kit
- Prilovix Lite Topical Kit
- Prilovix Lite Plus Topical Kit
- Prilolid Topical Kit
- Prikaan Topical Kit
- Prikaan Lite Topical Kit
- Medolor Pak Topical Kit
- Livixil Pak Topical Kit
- Liprozonepak Topical Kit
- Lidopril Xr Topical Kit
- Lidopril Topical Kit
- Lidocaine-prilocaine Topical Kit
- Lido-prilo Caine Pack Topical Kit
- Leva Set Topical Kit
- Dermacinrx Prizopak Topical Kit
- Dermacinrx Empricaine Topical Kit
- Aprizio Pak Topical Kit
- Anodyne Lpt Topical Kit
- Agoneaze Topical Kit
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
Prilovix 2.5 %-2.5 % topical kit
- Dosage information is not available
Plus 2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
Prikaan 2.5 %-2.5 % topical kit
- Dosage information is not available
Lite 2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
XR 2.5 %-2.5 % topical kit
- Dosage information is not available
Lidopril 2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
2.5 %-2.5 % topical kit
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Large open wound
- Methemoglobinemia
Contraindicated
- Cardiac arrhythmia
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency
- Heart block
- Hemolytic anemia from PK and g6PD deficiencies
- Sepsis
- Shock
Severe
Moderate
- Disease of liver
- Respiratory depression
- Seizure disorder
RELADOR PAK (LIDOCAINE/PRILOCAINE)
- Administration of local anesthesia
- None
- Localized edema
- Pallor
- Pruritus of skin
- Skin rash
- Treatment site sequelae
- Vasodilation of blood vessels
More Frequent
Severe
Less Severe
- None
- None
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Bradycardia
- CNS toxicity
- Drowsy
- Headache disorder
- Hypotension
- Methemoglobinemia
- Respiratory depression
- Seizure disorder
Less Severe
- None
Contraindicated
None
Severe Precaution
Lidocaine (Top)
Rare risk of methemoglobinemia in infants age < 6 months. Use dose based on age, body weight and physical condition.
Rare risk of methemoglobinemia in infants age < 6 months. Adhere closely to dosing guidelines age < 10 years.
- 1 Day – 179 Days
- Rare risk of methemoglobinemia in infants age < 6 months. Use dose based on age, body weight and physical condition.
Prilocaine
Rare risk of methemoglobinemia in infants age < 6 months. Use dose based on age, body weight and physical condition.
Rare risk of methemoglobinemia in infants age < 6 months. Adhere closely to dosing guidelines age < 10 years.
- 1 Day – 179 Days
- Rare risk of methemoglobinemia in infants age < 6 months. Adhere closely to dosing guidelines age < 10 years.
Management or Monitoring Precaution
Lidocaine (Top)
Rare risk of methemoglobinemia. Use dose based on age, body weight and physical condition.
Rare risk of methemoglobinemia. Adhere closely to dosing guidelines age < 10 years.
- 180 Days – 13 Years
- Rare risk of methemoglobinemia. Use dose based on age, body weight and physical condition.
- 180 Days – 10 Years
- Rare risk of methemoglobinemia. Use dose based on age, body weight and physical condition.
Prilocaine
Rare risk of methemoglobinemia. Use dose based on age, body weight and physical condition.
Rare risk of methemoglobinemia. Adhere closely to dosing guidelines age < 10 years.
- 180 Days – 13 Years
- Rare risk of methemoglobinemia. Adhere closely to dosing guidelines age < 10 years.
- 180 Days – 10 Years
- Rare risk of methemoglobinemia. Adhere closely to dosing guidelines age < 10 years.
Lidocaine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Prilocaine Hydrochloride
- Severity Level:
2
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Prilocaine
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
Lidocaine
Amount excreted reported to be low with low infant oral bioavailability
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Excreted | Not known; no or inclusive data | Amount excreted reported to be low with low infant oral bioavailability |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Formulary Reference Tool